300642
vs
S
Shanghai Composite
300642
Over the past 12 months, Tellgen Corp has outperformed Shanghai Composite, delivering a return of +30% compared to the Shanghai Composite's +26% growth.
Stocks Performance
300642 vs Shanghai Composite
Performance Gap
300642 vs Shanghai Composite
Performance By Year
300642 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Tellgen Corp
Glance View
Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. The company is headquartered in Shanghai, Shanghai and currently employs 810 full-time employees. The company went IPO on 2017-04-21. The firm's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic products, including tumor marker detection products, human papillomavirus (HPV) nucleic acid testing products, autoimmune disease detection products and lung cancer methylation mutation detection products.
